| type : |
Artikel |
| internetlink : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=3804 |
|
| onderzoeksgroepen : |
Nablus - An-Najah National University, Faculty of Medicines and Health Sciences |
| Auteur : |
Zaid Abdel Naser, Assali M, Qaddomi A, Ghanem M, Zaaror Yara Abu. |
| titel : |
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets. |
| Nummer : |
Int J Pharm Compound ; 18, 2 : 169-174. 2014 |
|
| Niveau van bewijs : |
|
| fysische stabiliteit : |
|
| chemische stabiliteit : |
|
| andere methoden : |
|
| Reacties : |
|
Stoffenlijst
 Valsartan
|
 |
 |
 |
 |
400 mg
Valzan® (Pharmacare PLC) |
| xanthaangom |
20 mg |
| hydroxypropylcellulose |
20 mg |
| Aerosil® |
110 mg |
| bananensmaak |
20 mg |
| Natriumfosfaat |
80 mg |
| Titaandioxide |
1 mg |
| aardbeiensmaak |
110 mg |
| sucrose |
22,04 g |
| gezuiverd water |
>> 25 mL |
|
23-27°C |
 |
| 30 |
 |
|
|
|
|
|
400 mg
Valzan® (Pharmacare PLC) |
| xanthaangom |
20 mg |
| hydroxypropylcellulose |
20 mg |
| Aerosil® |
110 mg |
| bananensmaak |
20 mg |
| Natriumfosfaat |
80 mg |
| Titaandioxide |
1 mg |
| aardbeiensmaak |
110 mg |
| sucrose |
22,04 g |
| gezuiverd water |
>> 25 mL |
|
38-42°C |
|
| 30 |
|
|
|
|
|
